Data Analysis and Suggestions on Unqualified Compound Danshen Tablets from Drug Sampling based on NMPA Drug Quality Announcement

Jie Hengbo, Li Wenhan, Zhang Cuilian, Zuo Wei

Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (9) : 1001-1007.

Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (9) : 1001-1007. DOI: 10.16153/j.1002-7777.20240385
Supervision & Administration

Data Analysis and Suggestions on Unqualified Compound Danshen Tablets from Drug Sampling based on NMPA Drug Quality Announcement

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 38(9): 1001-1007 https://doi.org/10.16153/j.1002-7777.20240385

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉